News

Biotronik, home monitoring, Biotronik Home Monitoring, BIOTRONIK

Biotronik announced the highly-anticipated results of the Reform study. The study demonstrates that ICD (implantable cardioverter-defibrillator) patients with Biotronik's Home Monitoring...

The U.S. Food and Drug Administration (FDA) announced a final rule for the unique device identification system (UDI) that, once implemented, will provide a consistent way to identify...

A new study of patients who died of sudden cardiac arrest, a usually fatal condition that causes the heart to stop beating, shows the majority who qualified to receive potentially lifesaving...

Physio-Control launched its comprehensive solution designed to improve cardiac resuscitation in hospitals. The CodeManagement Module, which adds capnography and wireless data capabilities to the...

Corindus CorPath 200 RECISION Registry Clinical Trial

Corindus Vascular Robotics announced the PRECISION Registry, an ongoing study aimed at collecting data on the patterns of use, safety and effectiveness in the delivery and manipulation of...

Vascular closure devices have a definite niche in areas where they were not originally intended but have found frequent off-label use because of their utility.

vascular closure device

Vascular closure devices (VCD) were first introduced in the early 1990s with a goal to achieve quick hemostasis, thus reducing patients’ stay in the hospital (shorter time to ambulation) as...

CardioMEMs

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee will review two new technologies to help treat heart failure (HF) Oct. 8-9,...

LINC Study Resuscitation Devices Defibrillator CPR Lucas Chest Compression

The main results of the large randomized LINC study, which compared the effectiveness of the Lucas mechanical chest compression system to high quality manual chest compressions, were...

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and...

Physio-Control launched its comprehensive solution designed to improve cardiac resuscitation in hospitals. The CodeManagement...

Carto 3, Biosense Webster, CartoUnivu

Nationwide data show that although only about 12 percent of X-ray exams are for interventional cardiology or electrophysiology (EP) procedures, nearly 50 percent of a patient’s lifetime radiation...

When a beating heart slips into an irregular, life-threatening rhythm, the treatment is well known: deliver a burst of electric current from a pacemaker or defibrillator. But...

Researchers announced this week that an attempt to expand cardiac resynchronization therapy (CRT) to include more patients with heart failure has failed and an international clinical trial ended...

This webinar focuses on how robotic-assistance can serve to optimize percutaneous coronary interventions (PCI). This talk explains the value of robotic-assistance in the cath lab, which includes...

EP Lab, EP mapping/imaging systems, Ablation systems

St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval and first use of MediGuide Enable Ablation Catheters. The ablation catheters, which are used to treat...

The U.S. Food and Drug Administration (FDA) approved Boston Scientific’s IntellaTip MiFi XP catheter and granted 510(k) clearance for the Zurpaz 8.5 French steerable sheath for electrophysiology (...

August 20, 2013 — St. Jude Medical Inc. announced the acquisition of Endosense SA, a Switzerland-based company that has pioneered contact-force measurement in catheter ablation. The acquisition...

Tyrx AIGISRx R Fully Resorbable Antibacterial Envelope Implantation

The first implantation of Tyrx Inc.’s new AigisRx R Fully Resorbable Antibacterial Envelope has taken place at the Vanderbilt Heart and Vascular Institute in Nashville, Tenn., by Christopher R....

The U.S. Food and Drug Administration (FDA) accepted Biomedica’s Investigational New Drug (IND) application for ClotFoam, a novel hemostat for intraoperative hemorrhage. The company will now...